跳至主要内容
临床试验/EUCTR2015-002769-44-AT
EUCTR2015-002769-44-AT进行中(未招募)1 期

Efficacy and safety of an accelerated outpatient protocol forhymenoptera venom immunotherapy - ESAP

Medical University of Graz0 个研究点目标入组 152 人开始时间: 2015年9月4日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
152

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Legally competent male and female subjects with a history of systemic anaphylactic sting reaction (= grade I according to the classification of Ring and Messmer)
  • Age =18 and =70 years
  • Written consent of the participant after being informed
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 120
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 32

排除标准

  • Simultaneous participation in another clinical trial
  • Nursing women
  • Absolute contraindication(s) for VIT:
  • - Uncontrolled Asthma
  • - Autoimmune disorders in active forms (nonresponding to treatment)
  • - Pregnancy
  • · Pretreatment with Omalizumab

研究者

发起方
Medical University of Graz

相似试验